Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Debt to Equity (2021)

Historic Debt to Equity for Barinthus Biotherapeutics (BRNS) over the last 1 years, with Q4 2021 value amounting to $0.0.

  • Barinthus Biotherapeutics' Debt to Equity changed N/A to $0.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $0.0, marking a year-over-year change of. This contributed to the annual value of $0.0 for FY2021, which is N/A changed from last year.
  • As of Q4 2021, Barinthus Biotherapeutics' Debt to Equity stood at $0.0.
  • In the past 5 years, Barinthus Biotherapeutics' Debt to Equity registered a high of $0.0 during Q4 2021, and its lowest value of $0.0 during Q4 2021.